Stock AnalizHealthcare Services Group Inc. HCSG
Hospital/Nursing Management · IPO 1983 · data as of November 13, 2026
Healthcare Services Group Inc. (HCSG) is a healthcare company listed in the US with a market value of about $1.7B. In the twelve months to September 30, 2026 it had revenue of $1.9B and net income of $105M, a net margin of 5.6%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is future growth (1/5).
Key numbers: a P/E of 16.8, a price to free cash flow of 15.7, 5-year revenue growth of 1% a year, a 5-year average ROIC of 9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 24% below the current price.
Score: 2.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $1.7B | $1.7B | $1.7B | $1.6B | $1.8B | $1.8B | $2.0B | $1.9B | $1.6B |
| Net income | $105M | $59M | $39M | $38M | $34M | $49M | $99M | $65M | $84M | $88M | $77M |
| Free cash flow | $107M | $139M | $24M | $38M | -$13M | $31M | $213M | $89M | $75M | $2M | $36M |
| EPS (diluted) | $1.48 | $0.81 | $0.53 | $0.52 | $0.46 | $0.65 | $1.32 | $0.87 | $1.12 | $1.19 | $1.05 |
| Net margin | 5.6% | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | 5.0% |
| ROIC | — | 11.2% | 7.6% | 7.7% | 7.5% | 10.5% | 20.3% | 14.1% | 19.5% | 22.3% | 22.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 6 analysts is $26.67, 7% above the current price; targets range from $24.00 to $30.00; the consensus rating is “Buy”; expected EPS is $1.34 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Healthcare Services Group’s P/E ratio?
About 16.8, based on the last twelve months of diluted earnings per share (forward P/E about 20.9).
Is Healthcare Services Group stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 24% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Healthcare Services Group pay a dividend?
Not currently.
Is Healthcare Services Group a good stock to buy?
We do not give buy or sell advice. Healthcare Services Group scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.